Tough spot—everyone rationalizes the trade-off between integrity and comfort differently. But if you’re already this bitter, maybe the exit’s overdue. Reminds me of Eli Lilly dropping $2.75B on AI-designed drugs—big money shapes outcomes, but the sellout’s only worth it if you don’t hate...